FDA backs expanded use of medical abortion pill
Wed Mar 30, 2016 3:18pm EDT - The U.S. Food and Drug Administration on Wednesday agreed to allow more access to Danco Laboratories' abortion pill Mifeprex, likely making it easier and cheaper for women to have an abortion by medication.
The FDA increased authorized use of the pill to 70 days of gestation from the current 49 days, cut the recommended dose of the drug and reduced the number of required visits to a doctor.
The changes are expected to allow greater access to medication abortions, particularly in Texas, North Dakota and Ohio, which have laws that require providers to prescribe the drug according to a more restrictive FDA label in place since 2000.
On Wednesday, the agency updated the Mifepfrex requirements to bring them in line with the most up-to-date scientific studies, which have shown that a third of the dose works as well.
-
Source